nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—S100B—blood vessel—stomach cancer	0.0216	0.0835	CbGeAlD
Olopatadine—S100A2—hematopoietic system—stomach cancer	0.0144	0.0559	CbGeAlD
Olopatadine—S100A2—epithelium—stomach cancer	0.0132	0.0511	CbGeAlD
Olopatadine—S100A2—pancreas—stomach cancer	0.0117	0.0455	CbGeAlD
Olopatadine—S100A12—hematopoietic system—stomach cancer	0.0116	0.0451	CbGeAlD
Olopatadine—S100B—hematopoietic system—stomach cancer	0.0115	0.0445	CbGeAlD
Olopatadine—S100A13—epithelium—stomach cancer	0.0108	0.0418	CbGeAlD
Olopatadine—S100A12—epithelium—stomach cancer	0.0106	0.0412	CbGeAlD
Olopatadine—S100A13—smooth muscle tissue—stomach cancer	0.0104	0.0402	CbGeAlD
Olopatadine—S100A2—lymphoid tissue—stomach cancer	0.0102	0.0394	CbGeAlD
Olopatadine—S100A1—digestive system—stomach cancer	0.00924	0.0358	CbGeAlD
Olopatadine—S100A2—endocrine gland—stomach cancer	0.00829	0.0321	CbGeAlD
Olopatadine—S100A13—digestive system—stomach cancer	0.0082	0.0318	CbGeAlD
Olopatadine—S100A12—lymphoid tissue—stomach cancer	0.00819	0.0317	CbGeAlD
Olopatadine—S100A12—digestive system—stomach cancer	0.00809	0.0313	CbGeAlD
Olopatadine—S100B—lymphoid tissue—stomach cancer	0.00808	0.0313	CbGeAlD
Olopatadine—S100A1—endocrine gland—stomach cancer	0.00764	0.0296	CbGeAlD
Olopatadine—S100A12—bone marrow—stomach cancer	0.00746	0.0289	CbGeAlD
Olopatadine—S100A13—endocrine gland—stomach cancer	0.00677	0.0262	CbGeAlD
Olopatadine—S100A12—endocrine gland—stomach cancer	0.00668	0.0259	CbGeAlD
Olopatadine—S100B—endocrine gland—stomach cancer	0.0066	0.0256	CbGeAlD
Olopatadine—S100A13—liver—stomach cancer	0.00611	0.0237	CbGeAlD
Olopatadine—S100A12—liver—stomach cancer	0.00603	0.0233	CbGeAlD
Olopatadine—S100A1—lymph node—stomach cancer	0.00528	0.0205	CbGeAlD
Olopatadine—S100A13—lymph node—stomach cancer	0.00468	0.0181	CbGeAlD
Olopatadine—S100A12—lymph node—stomach cancer	0.00462	0.0179	CbGeAlD
Olopatadine—S100B—lymph node—stomach cancer	0.00456	0.0177	CbGeAlD
Olopatadine—HRH1—hematopoietic system—stomach cancer	0.00235	0.00912	CbGeAlD
Olopatadine—HRH1—epithelium—stomach cancer	0.00215	0.00834	CbGeAlD
Olopatadine—HRH1—smooth muscle tissue—stomach cancer	0.00207	0.00803	CbGeAlD
Olopatadine—Doxepin—HRH4—stomach cancer	0.00205	0.201	CrCbGaD
Olopatadine—CYP3A4—hematopoietic system—stomach cancer	0.00182	0.00705	CbGeAlD
Olopatadine—HRH1—digestive system—stomach cancer	0.00164	0.00634	CbGeAlD
Olopatadine—Amitriptyline—HRH4—stomach cancer	0.00158	0.155	CrCbGaD
Olopatadine—HRH1—endocrine gland—stomach cancer	0.00135	0.00524	CbGeAlD
Olopatadine—CYP3A4—digestive system—stomach cancer	0.00127	0.0049	CbGeAlD
Olopatadine—Clomipramine—GSTP1—stomach cancer	0.00108	0.105	CrCbGaD
Olopatadine—CYP3A4—endocrine gland—stomach cancer	0.00105	0.00405	CbGeAlD
Olopatadine—CYP3A4—liver—stomach cancer	0.000943	0.00365	CbGeAlD
Olopatadine—HRH1—lymph node—stomach cancer	0.000935	0.00362	CbGeAlD
Olopatadine—Acepromazine—HTR1A—stomach cancer	0.000888	0.087	CrCbGaD
Olopatadine—Thiothixene—HTR1A—stomach cancer	0.000854	0.0837	CrCbGaD
Olopatadine—Pharyngitis—Capecitabine—stomach cancer	0.000676	0.00192	CcSEcCtD
Olopatadine—Nortriptyline—HTR1A—stomach cancer	0.00066	0.0646	CrCbGaD
Olopatadine—Eye disorder—Docetaxel—stomach cancer	0.000658	0.00186	CcSEcCtD
Olopatadine—Visual impairment—Capecitabine—stomach cancer	0.000657	0.00186	CcSEcCtD
Olopatadine—Dyspnoea—Irinotecan—stomach cancer	0.000645	0.00183	CcSEcCtD
Olopatadine—Somnolence—Irinotecan—stomach cancer	0.000643	0.00182	CcSEcCtD
Olopatadine—Eye disorder—Capecitabine—stomach cancer	0.000637	0.0018	CcSEcCtD
Olopatadine—Immune system disorder—Docetaxel—stomach cancer	0.000636	0.0018	CcSEcCtD
Olopatadine—Mediastinal disorder—Docetaxel—stomach cancer	0.000634	0.0018	CcSEcCtD
Olopatadine—Dry skin—Epirubicin—stomach cancer	0.000629	0.00178	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000625	0.00177	CcSEcCtD
Olopatadine—Fatigue—Irinotecan—stomach cancer	0.000624	0.00177	CcSEcCtD
Olopatadine—Pain—Irinotecan—stomach cancer	0.000619	0.00175	CcSEcCtD
Olopatadine—Dyspnoea—Fluorouracil—stomach cancer	0.000618	0.00175	CcSEcCtD
Olopatadine—Somnolence—Fluorouracil—stomach cancer	0.000616	0.00174	CcSEcCtD
Olopatadine—Immune system disorder—Capecitabine—stomach cancer	0.000616	0.00174	CcSEcCtD
Olopatadine—Mediastinal disorder—Capecitabine—stomach cancer	0.000614	0.00174	CcSEcCtD
Olopatadine—Nasopharyngitis—Epirubicin—stomach cancer	0.000614	0.00174	CcSEcCtD
Olopatadine—Erythema—Docetaxel—stomach cancer	0.000613	0.00174	CcSEcCtD
Olopatadine—Dysgeusia—Docetaxel—stomach cancer	0.0006	0.0017	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000598	0.00169	CcSEcCtD
Olopatadine—Feeling abnormal—Irinotecan—stomach cancer	0.000596	0.00169	CcSEcCtD
Olopatadine—Erythema—Capecitabine—stomach cancer	0.000593	0.00168	CcSEcCtD
Olopatadine—Influenza—Epirubicin—stomach cancer	0.000593	0.00168	CcSEcCtD
Olopatadine—Back pain—Docetaxel—stomach cancer	0.000593	0.00168	CcSEcCtD
Olopatadine—Pain—Fluorouracil—stomach cancer	0.000593	0.00168	CcSEcCtD
Olopatadine—Doxepin—HTR1A—stomach cancer	0.000592	0.058	CrCbGaD
Olopatadine—Gastrointestinal pain—Irinotecan—stomach cancer	0.000592	0.00168	CcSEcCtD
Olopatadine—Muscle spasms—Docetaxel—stomach cancer	0.000589	0.00167	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Methotrexate—stomach cancer	0.000589	0.00167	CcSEcCtD
Olopatadine—Dry skin—Doxorubicin—stomach cancer	0.000582	0.00165	CcSEcCtD
Olopatadine—Dysgeusia—Capecitabine—stomach cancer	0.000581	0.00165	CcSEcCtD
Olopatadine—Back pain—Capecitabine—stomach cancer	0.000574	0.00163	CcSEcCtD
Olopatadine—Body temperature increased—Irinotecan—stomach cancer	0.000572	0.00162	CcSEcCtD
Olopatadine—Abdominal pain—Irinotecan—stomach cancer	0.000572	0.00162	CcSEcCtD
Olopatadine—Feeling abnormal—Fluorouracil—stomach cancer	0.000571	0.00162	CcSEcCtD
Olopatadine—Muscle spasms—Capecitabine—stomach cancer	0.00057	0.00162	CcSEcCtD
Olopatadine—Nasopharyngitis—Doxorubicin—stomach cancer	0.000568	0.00161	CcSEcCtD
Olopatadine—Infestation—Methotrexate—stomach cancer	0.000565	0.0016	CcSEcCtD
Olopatadine—Infestation NOS—Methotrexate—stomach cancer	0.000565	0.0016	CcSEcCtD
Olopatadine—Depression—Methotrexate—stomach cancer	0.000564	0.0016	CcSEcCtD
Olopatadine—Vision blurred—Capecitabine—stomach cancer	0.000559	0.00158	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Epirubicin—stomach cancer	0.000551	0.00156	CcSEcCtD
Olopatadine—Ill-defined disorder—Capecitabine—stomach cancer	0.000551	0.00156	CcSEcCtD
Olopatadine—Conjunctivitis—Methotrexate—stomach cancer	0.000549	0.00156	CcSEcCtD
Olopatadine—Influenza—Doxorubicin—stomach cancer	0.000549	0.00155	CcSEcCtD
Olopatadine—Body temperature increased—Fluorouracil—stomach cancer	0.000548	0.00155	CcSEcCtD
Olopatadine—Weight increased—Epirubicin—stomach cancer	0.00054	0.00153	CcSEcCtD
Olopatadine—Malaise—Capecitabine—stomach cancer	0.000535	0.00152	CcSEcCtD
Olopatadine—Cough—Docetaxel—stomach cancer	0.000535	0.00151	CcSEcCtD
Olopatadine—Epistaxis—Methotrexate—stomach cancer	0.000533	0.00151	CcSEcCtD
Olopatadine—Hypersensitivity—Irinotecan—stomach cancer	0.000533	0.00151	CcSEcCtD
Olopatadine—Infestation NOS—Epirubicin—stomach cancer	0.000529	0.0015	CcSEcCtD
Olopatadine—Infestation—Epirubicin—stomach cancer	0.000529	0.0015	CcSEcCtD
Olopatadine—Asthenia—Irinotecan—stomach cancer	0.000519	0.00147	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000518	0.00147	CcSEcCtD
Olopatadine—Cough—Capecitabine—stomach cancer	0.000518	0.00147	CcSEcCtD
Olopatadine—Urinary tract infection—Epirubicin—stomach cancer	0.000514	0.00146	CcSEcCtD
Olopatadine—Conjunctivitis—Epirubicin—stomach cancer	0.000514	0.00146	CcSEcCtD
Olopatadine—Hypersensitivity—Fluorouracil—stomach cancer	0.000511	0.00145	CcSEcCtD
Olopatadine—Dry mouth—Docetaxel—stomach cancer	0.00051	0.00145	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.00051	0.00145	CcSEcCtD
Olopatadine—Pharyngitis—Methotrexate—stomach cancer	0.000504	0.00143	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000502	0.00142	CcSEcCtD
Olopatadine—Oedema—Docetaxel—stomach cancer	0.0005	0.00142	CcSEcCtD
Olopatadine—Weight increased—Doxorubicin—stomach cancer	0.0005	0.00141	CcSEcCtD
Olopatadine—Discomfort—Capecitabine—stomach cancer	0.000499	0.00141	CcSEcCtD
Olopatadine—Epistaxis—Epirubicin—stomach cancer	0.000499	0.00141	CcSEcCtD
Olopatadine—Infection—Docetaxel—stomach cancer	0.000497	0.00141	CcSEcCtD
Olopatadine—Sinusitis—Epirubicin—stomach cancer	0.000496	0.00141	CcSEcCtD
Olopatadine—Diarrhoea—Irinotecan—stomach cancer	0.000495	0.0014	CcSEcCtD
Olopatadine—Dry mouth—Capecitabine—stomach cancer	0.000494	0.0014	CcSEcCtD
Olopatadine—Nervous system disorder—Docetaxel—stomach cancer	0.00049	0.00139	CcSEcCtD
Olopatadine—Pruritus—Fluorouracil—stomach cancer	0.00049	0.00139	CcSEcCtD
Olopatadine—Infestation NOS—Doxorubicin—stomach cancer	0.000489	0.00139	CcSEcCtD
Olopatadine—Infestation—Doxorubicin—stomach cancer	0.000489	0.00139	CcSEcCtD
Olopatadine—Visual impairment—Methotrexate—stomach cancer	0.000489	0.00139	CcSEcCtD
Olopatadine—Skin disorder—Docetaxel—stomach cancer	0.000486	0.00138	CcSEcCtD
Olopatadine—Oedema—Capecitabine—stomach cancer	0.000484	0.00137	CcSEcCtD
Olopatadine—Infection—Capecitabine—stomach cancer	0.000481	0.00136	CcSEcCtD
Olopatadine—Dizziness—Irinotecan—stomach cancer	0.000478	0.00136	CcSEcCtD
Olopatadine—Rhinitis—Epirubicin—stomach cancer	0.000476	0.00135	CcSEcCtD
Olopatadine—Conjunctivitis—Doxorubicin—stomach cancer	0.000476	0.00135	CcSEcCtD
Olopatadine—Urinary tract infection—Doxorubicin—stomach cancer	0.000476	0.00135	CcSEcCtD
Olopatadine—Nervous system disorder—Capecitabine—stomach cancer	0.000475	0.00135	CcSEcCtD
Olopatadine—Eye disorder—Methotrexate—stomach cancer	0.000474	0.00134	CcSEcCtD
Olopatadine—Diarrhoea—Fluorouracil—stomach cancer	0.000474	0.00134	CcSEcCtD
Olopatadine—Hypoaesthesia—Epirubicin—stomach cancer	0.000472	0.00134	CcSEcCtD
Olopatadine—Pharyngitis—Epirubicin—stomach cancer	0.000471	0.00133	CcSEcCtD
Olopatadine—Skin disorder—Capecitabine—stomach cancer	0.00047	0.00133	CcSEcCtD
Olopatadine—Epistaxis—Doxorubicin—stomach cancer	0.000462	0.00131	CcSEcCtD
Olopatadine—Imipramine—HTR1A—stomach cancer	0.000461	0.0451	CrCbGaD
Olopatadine—Vomiting—Irinotecan—stomach cancer	0.00046	0.0013	CcSEcCtD
Olopatadine—Sinusitis—Doxorubicin—stomach cancer	0.000459	0.0013	CcSEcCtD
Olopatadine—Immune system disorder—Methotrexate—stomach cancer	0.000458	0.0013	CcSEcCtD
Olopatadine—Dizziness—Fluorouracil—stomach cancer	0.000458	0.0013	CcSEcCtD
Olopatadine—Amitriptyline—HTR1A—stomach cancer	0.000458	0.0449	CrCbGaD
Olopatadine—Visual impairment—Epirubicin—stomach cancer	0.000458	0.0013	CcSEcCtD
Olopatadine—Mediastinal disorder—Methotrexate—stomach cancer	0.000457	0.0013	CcSEcCtD
Olopatadine—Rash—Irinotecan—stomach cancer	0.000456	0.00129	CcSEcCtD
Olopatadine—Dermatitis—Irinotecan—stomach cancer	0.000456	0.00129	CcSEcCtD
Olopatadine—Headache—Irinotecan—stomach cancer	0.000453	0.00128	CcSEcCtD
Olopatadine—Dyspnoea—Docetaxel—stomach cancer	0.000446	0.00126	CcSEcCtD
Olopatadine—Somnolence—Docetaxel—stomach cancer	0.000445	0.00126	CcSEcCtD
Olopatadine—Eye disorder—Epirubicin—stomach cancer	0.000444	0.00126	CcSEcCtD
Olopatadine—Erythema—Methotrexate—stomach cancer	0.000442	0.00125	CcSEcCtD
Olopatadine—Vomiting—Fluorouracil—stomach cancer	0.000441	0.00125	CcSEcCtD
Olopatadine—Rhinitis—Doxorubicin—stomach cancer	0.00044	0.00125	CcSEcCtD
Olopatadine—Hypoaesthesia—Doxorubicin—stomach cancer	0.000437	0.00124	CcSEcCtD
Olopatadine—Rash—Fluorouracil—stomach cancer	0.000437	0.00124	CcSEcCtD
Olopatadine—Dermatitis—Fluorouracil—stomach cancer	0.000437	0.00124	CcSEcCtD
Olopatadine—Pharyngitis—Doxorubicin—stomach cancer	0.000436	0.00124	CcSEcCtD
Olopatadine—Headache—Fluorouracil—stomach cancer	0.000434	0.00123	CcSEcCtD
Olopatadine—Dysgeusia—Methotrexate—stomach cancer	0.000433	0.00123	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000432	0.00122	CcSEcCtD
Olopatadine—Dyspnoea—Capecitabine—stomach cancer	0.000432	0.00122	CcSEcCtD
Olopatadine—Fatigue—Docetaxel—stomach cancer	0.000431	0.00122	CcSEcCtD
Olopatadine—Nausea—Irinotecan—stomach cancer	0.00043	0.00122	CcSEcCtD
Olopatadine—Immune system disorder—Epirubicin—stomach cancer	0.000429	0.00121	CcSEcCtD
Olopatadine—Mediastinal disorder—Epirubicin—stomach cancer	0.000428	0.00121	CcSEcCtD
Olopatadine—Pain—Docetaxel—stomach cancer	0.000428	0.00121	CcSEcCtD
Olopatadine—Back pain—Methotrexate—stomach cancer	0.000427	0.00121	CcSEcCtD
Olopatadine—Visual impairment—Doxorubicin—stomach cancer	0.000423	0.0012	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000418	0.00118	CcSEcCtD
Olopatadine—Fatigue—Capecitabine—stomach cancer	0.000417	0.00118	CcSEcCtD
Olopatadine—Vision blurred—Methotrexate—stomach cancer	0.000416	0.00118	CcSEcCtD
Olopatadine—Pain—Capecitabine—stomach cancer	0.000414	0.00117	CcSEcCtD
Olopatadine—Erythema—Epirubicin—stomach cancer	0.000413	0.00117	CcSEcCtD
Olopatadine—Feeling abnormal—Docetaxel—stomach cancer	0.000412	0.00117	CcSEcCtD
Olopatadine—Nausea—Fluorouracil—stomach cancer	0.000412	0.00117	CcSEcCtD
Olopatadine—Eye disorder—Doxorubicin—stomach cancer	0.000411	0.00116	CcSEcCtD
Olopatadine—Ill-defined disorder—Methotrexate—stomach cancer	0.00041	0.00116	CcSEcCtD
Olopatadine—Gastrointestinal pain—Docetaxel—stomach cancer	0.000409	0.00116	CcSEcCtD
Olopatadine—Dysgeusia—Epirubicin—stomach cancer	0.000405	0.00115	CcSEcCtD
Olopatadine—Back pain—Epirubicin—stomach cancer	0.0004	0.00113	CcSEcCtD
Olopatadine—Feeling abnormal—Capecitabine—stomach cancer	0.000399	0.00113	CcSEcCtD
Olopatadine—Acepromazine—ALB—stomach cancer	0.000399	0.0391	CrCbGaD
Olopatadine—Malaise—Methotrexate—stomach cancer	0.000398	0.00113	CcSEcCtD
Olopatadine—Muscle spasms—Epirubicin—stomach cancer	0.000397	0.00113	CcSEcCtD
Olopatadine—Immune system disorder—Doxorubicin—stomach cancer	0.000397	0.00112	CcSEcCtD
Olopatadine—Gastrointestinal pain—Capecitabine—stomach cancer	0.000396	0.00112	CcSEcCtD
Olopatadine—Mediastinal disorder—Doxorubicin—stomach cancer	0.000396	0.00112	CcSEcCtD
Olopatadine—Abdominal pain—Docetaxel—stomach cancer	0.000395	0.00112	CcSEcCtD
Olopatadine—Body temperature increased—Docetaxel—stomach cancer	0.000395	0.00112	CcSEcCtD
Olopatadine—Vision blurred—Epirubicin—stomach cancer	0.00039	0.0011	CcSEcCtD
Olopatadine—Cough—Methotrexate—stomach cancer	0.000385	0.00109	CcSEcCtD
Olopatadine—Ill-defined disorder—Epirubicin—stomach cancer	0.000384	0.00109	CcSEcCtD
Olopatadine—Thiothixene—ALB—stomach cancer	0.000383	0.0376	CrCbGaD
Olopatadine—Body temperature increased—Capecitabine—stomach cancer	0.000383	0.00108	CcSEcCtD
Olopatadine—Abdominal pain—Capecitabine—stomach cancer	0.000383	0.00108	CcSEcCtD
Olopatadine—Erythema—Doxorubicin—stomach cancer	0.000382	0.00108	CcSEcCtD
Olopatadine—Dysgeusia—Doxorubicin—stomach cancer	0.000375	0.00106	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000373	0.00106	CcSEcCtD
Olopatadine—Malaise—Epirubicin—stomach cancer	0.000373	0.00106	CcSEcCtD
Olopatadine—Discomfort—Methotrexate—stomach cancer	0.000372	0.00105	CcSEcCtD
Olopatadine—Back pain—Doxorubicin—stomach cancer	0.00037	0.00105	CcSEcCtD
Olopatadine—Hypersensitivity—Docetaxel—stomach cancer	0.000368	0.00104	CcSEcCtD
Olopatadine—Muscle spasms—Doxorubicin—stomach cancer	0.000368	0.00104	CcSEcCtD
Olopatadine—Cough—Epirubicin—stomach cancer	0.000361	0.00102	CcSEcCtD
Olopatadine—Vision blurred—Doxorubicin—stomach cancer	0.00036	0.00102	CcSEcCtD
Olopatadine—Asthenia—Docetaxel—stomach cancer	0.000359	0.00102	CcSEcCtD
Olopatadine—Infection—Methotrexate—stomach cancer	0.000358	0.00101	CcSEcCtD
Olopatadine—Hypersensitivity—Capecitabine—stomach cancer	0.000357	0.00101	CcSEcCtD
Olopatadine—Ill-defined disorder—Doxorubicin—stomach cancer	0.000355	0.00101	CcSEcCtD
Olopatadine—Pruritus—Docetaxel—stomach cancer	0.000354	0.001	CcSEcCtD
Olopatadine—Nervous system disorder—Methotrexate—stomach cancer	0.000354	0.001	CcSEcCtD
Olopatadine—Skin disorder—Methotrexate—stomach cancer	0.00035	0.000992	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000349	0.00099	CcSEcCtD
Olopatadine—Discomfort—Epirubicin—stomach cancer	0.000348	0.000985	CcSEcCtD
Olopatadine—Asthenia—Capecitabine—stomach cancer	0.000347	0.000984	CcSEcCtD
Olopatadine—Malaise—Doxorubicin—stomach cancer	0.000345	0.000977	CcSEcCtD
Olopatadine—Dry mouth—Epirubicin—stomach cancer	0.000344	0.000975	CcSEcCtD
Olopatadine—Pruritus—Capecitabine—stomach cancer	0.000343	0.00097	CcSEcCtD
Olopatadine—Diarrhoea—Docetaxel—stomach cancer	0.000342	0.000969	CcSEcCtD
Olopatadine—Oedema—Epirubicin—stomach cancer	0.000337	0.000956	CcSEcCtD
Olopatadine—Infection—Epirubicin—stomach cancer	0.000335	0.000949	CcSEcCtD
Olopatadine—Cough—Doxorubicin—stomach cancer	0.000334	0.000945	CcSEcCtD
Olopatadine—Diarrhoea—Capecitabine—stomach cancer	0.000331	0.000939	CcSEcCtD
Olopatadine—Nervous system disorder—Epirubicin—stomach cancer	0.000331	0.000937	CcSEcCtD
Olopatadine—Dizziness—Docetaxel—stomach cancer	0.000331	0.000937	CcSEcCtD
Olopatadine—Skin disorder—Epirubicin—stomach cancer	0.000328	0.000928	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000323	0.000916	CcSEcCtD
Olopatadine—Discomfort—Doxorubicin—stomach cancer	0.000322	0.000911	CcSEcCtD
Olopatadine—Dyspnoea—Methotrexate—stomach cancer	0.000321	0.00091	CcSEcCtD
Olopatadine—Somnolence—Methotrexate—stomach cancer	0.00032	0.000908	CcSEcCtD
Olopatadine—Dizziness—Capecitabine—stomach cancer	0.00032	0.000907	CcSEcCtD
Olopatadine—Dry mouth—Doxorubicin—stomach cancer	0.000318	0.000902	CcSEcCtD
Olopatadine—Vomiting—Docetaxel—stomach cancer	0.000318	0.000901	CcSEcCtD
Olopatadine—Rash—Docetaxel—stomach cancer	0.000315	0.000893	CcSEcCtD
Olopatadine—Dermatitis—Docetaxel—stomach cancer	0.000315	0.000892	CcSEcCtD
Olopatadine—Headache—Docetaxel—stomach cancer	0.000313	0.000888	CcSEcCtD
Olopatadine—Oedema—Doxorubicin—stomach cancer	0.000312	0.000884	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000311	0.000882	CcSEcCtD
Olopatadine—Fatigue—Methotrexate—stomach cancer	0.000311	0.00088	CcSEcCtD
Olopatadine—Infection—Doxorubicin—stomach cancer	0.00031	0.000878	CcSEcCtD
Olopatadine—Pain—Methotrexate—stomach cancer	0.000308	0.000873	CcSEcCtD
Olopatadine—Vomiting—Capecitabine—stomach cancer	0.000308	0.000872	CcSEcCtD
Olopatadine—Nervous system disorder—Doxorubicin—stomach cancer	0.000306	0.000867	CcSEcCtD
Olopatadine—Rash—Capecitabine—stomach cancer	0.000305	0.000865	CcSEcCtD
Olopatadine—Dermatitis—Capecitabine—stomach cancer	0.000305	0.000864	CcSEcCtD
Olopatadine—Headache—Capecitabine—stomach cancer	0.000303	0.000859	CcSEcCtD
Olopatadine—Skin disorder—Doxorubicin—stomach cancer	0.000303	0.000859	CcSEcCtD
Olopatadine—Clomipramine—ALB—stomach cancer	0.000303	0.0297	CrCbGaD
Olopatadine—Dyspnoea—Epirubicin—stomach cancer	0.000301	0.000852	CcSEcCtD
Olopatadine—Somnolence—Epirubicin—stomach cancer	0.0003	0.00085	CcSEcCtD
Olopatadine—Nausea—Docetaxel—stomach cancer	0.000297	0.000842	CcSEcCtD
Olopatadine—Feeling abnormal—Methotrexate—stomach cancer	0.000297	0.000841	CcSEcCtD
Olopatadine—Nortriptyline—ALB—stomach cancer	0.000296	0.029	CrCbGaD
Olopatadine—Gastrointestinal pain—Methotrexate—stomach cancer	0.000295	0.000835	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000291	0.000825	CcSEcCtD
Olopatadine—Fatigue—Epirubicin—stomach cancer	0.000291	0.000824	CcSEcCtD
Olopatadine—Pain—Epirubicin—stomach cancer	0.000288	0.000817	CcSEcCtD
Olopatadine—Nausea—Capecitabine—stomach cancer	0.000288	0.000815	CcSEcCtD
Olopatadine—Abdominal pain—Methotrexate—stomach cancer	0.000285	0.000807	CcSEcCtD
Olopatadine—Body temperature increased—Methotrexate—stomach cancer	0.000285	0.000807	CcSEcCtD
Olopatadine—Dyspnoea—Doxorubicin—stomach cancer	0.000278	0.000788	CcSEcCtD
Olopatadine—Feeling abnormal—Epirubicin—stomach cancer	0.000278	0.000787	CcSEcCtD
Olopatadine—Somnolence—Doxorubicin—stomach cancer	0.000277	0.000786	CcSEcCtD
Olopatadine—Gastrointestinal pain—Epirubicin—stomach cancer	0.000276	0.000781	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000269	0.000763	CcSEcCtD
Olopatadine—Fatigue—Doxorubicin—stomach cancer	0.000269	0.000762	CcSEcCtD
Olopatadine—Pain—Doxorubicin—stomach cancer	0.000267	0.000756	CcSEcCtD
Olopatadine—Abdominal pain—Epirubicin—stomach cancer	0.000267	0.000755	CcSEcCtD
Olopatadine—Body temperature increased—Epirubicin—stomach cancer	0.000267	0.000755	CcSEcCtD
Olopatadine—Hypersensitivity—Methotrexate—stomach cancer	0.000266	0.000752	CcSEcCtD
Olopatadine—Asthenia—Methotrexate—stomach cancer	0.000259	0.000733	CcSEcCtD
Olopatadine—Feeling abnormal—Doxorubicin—stomach cancer	0.000257	0.000729	CcSEcCtD
Olopatadine—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000255	0.000723	CcSEcCtD
Olopatadine—Pruritus—Methotrexate—stomach cancer	0.000255	0.000722	CcSEcCtD
Olopatadine—Hypersensitivity—Epirubicin—stomach cancer	0.000249	0.000704	CcSEcCtD
Olopatadine—Abdominal pain—Doxorubicin—stomach cancer	0.000247	0.000699	CcSEcCtD
Olopatadine—Body temperature increased—Doxorubicin—stomach cancer	0.000247	0.000699	CcSEcCtD
Olopatadine—Diarrhoea—Methotrexate—stomach cancer	0.000247	0.000699	CcSEcCtD
Olopatadine—Asthenia—Epirubicin—stomach cancer	0.000242	0.000686	CcSEcCtD
Olopatadine—Pruritus—Epirubicin—stomach cancer	0.000239	0.000676	CcSEcCtD
Olopatadine—Dizziness—Methotrexate—stomach cancer	0.000238	0.000675	CcSEcCtD
Olopatadine—Diarrhoea—Epirubicin—stomach cancer	0.000231	0.000654	CcSEcCtD
Olopatadine—Hypersensitivity—Doxorubicin—stomach cancer	0.00023	0.000651	CcSEcCtD
Olopatadine—Vomiting—Methotrexate—stomach cancer	0.000229	0.000649	CcSEcCtD
Olopatadine—Rash—Methotrexate—stomach cancer	0.000227	0.000644	CcSEcCtD
Olopatadine—Dermatitis—Methotrexate—stomach cancer	0.000227	0.000643	CcSEcCtD
Olopatadine—Headache—Methotrexate—stomach cancer	0.000226	0.00064	CcSEcCtD
Olopatadine—Asthenia—Doxorubicin—stomach cancer	0.000224	0.000634	CcSEcCtD
Olopatadine—Dizziness—Epirubicin—stomach cancer	0.000223	0.000632	CcSEcCtD
Olopatadine—Pruritus—Doxorubicin—stomach cancer	0.000221	0.000626	CcSEcCtD
Olopatadine—Vomiting—Epirubicin—stomach cancer	0.000214	0.000608	CcSEcCtD
Olopatadine—Nausea—Methotrexate—stomach cancer	0.000214	0.000607	CcSEcCtD
Olopatadine—Diarrhoea—Doxorubicin—stomach cancer	0.000214	0.000605	CcSEcCtD
Olopatadine—Rash—Epirubicin—stomach cancer	0.000213	0.000603	CcSEcCtD
Olopatadine—Dermatitis—Epirubicin—stomach cancer	0.000213	0.000602	CcSEcCtD
Olopatadine—Headache—Epirubicin—stomach cancer	0.000211	0.000599	CcSEcCtD
Olopatadine—Dizziness—Doxorubicin—stomach cancer	0.000206	0.000585	CcSEcCtD
Olopatadine—Amitriptyline—ALB—stomach cancer	0.000205	0.0201	CrCbGaD
Olopatadine—Nausea—Epirubicin—stomach cancer	0.0002	0.000568	CcSEcCtD
Olopatadine—Vomiting—Doxorubicin—stomach cancer	0.000198	0.000562	CcSEcCtD
Olopatadine—Rash—Doxorubicin—stomach cancer	0.000197	0.000557	CcSEcCtD
Olopatadine—Dermatitis—Doxorubicin—stomach cancer	0.000197	0.000557	CcSEcCtD
Olopatadine—Headache—Doxorubicin—stomach cancer	0.000196	0.000554	CcSEcCtD
Olopatadine—Nausea—Doxorubicin—stomach cancer	0.000185	0.000525	CcSEcCtD
Olopatadine—S100A12—Immune System—IL6ST—stomach cancer	0.000106	0.00028	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HRH4—stomach cancer	0.000106	0.000279	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—stomach cancer	0.000106	0.000279	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—KISS1—stomach cancer	0.000104	0.000274	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HBEGF—stomach cancer	0.000103	0.000271	CbGpPWpGaD
Olopatadine—S100B—Immune System—PRKCB—stomach cancer	0.000101	0.000265	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL6ST—stomach cancer	0.0001	0.000264	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—GSTT1—stomach cancer	9.98e-05	0.000263	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—MAPK3—stomach cancer	9.88e-05	0.000261	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	9.86e-05	0.00026	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—ADRB2—stomach cancer	9.48e-05	0.00025	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CASP8—stomach cancer	9.48e-05	0.00025	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	9.46e-05	0.00025	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL6R—stomach cancer	9.45e-05	0.000249	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—stomach cancer	9.44e-05	0.000249	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—KISS1—stomach cancer	9.43e-05	0.000249	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—MAPK1—stomach cancer	9.4e-05	0.000248	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—EGFR—stomach cancer	9.4e-05	0.000248	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CDH1—stomach cancer	9.36e-05	0.000247	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—MAPK3—stomach cancer	9.35e-05	0.000247	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PPP2R1A—stomach cancer	9.29e-05	0.000245	CbGpPWpGaD
Olopatadine—S100B—Immune System—CASP8—stomach cancer	8.96e-05	0.000237	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL6R—stomach cancer	8.93e-05	0.000236	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—RGS2—stomach cancer	8.93e-05	0.000236	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—GAST—stomach cancer	8.93e-05	0.000236	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—MAPK1—stomach cancer	8.89e-05	0.000235	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—EGFR—stomach cancer	8.89e-05	0.000235	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—KRAS—stomach cancer	8.88e-05	0.000235	CbGpPWpGaD
Olopatadine—S100B—Immune System—CDH1—stomach cancer	8.85e-05	0.000234	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—ADRB2—stomach cancer	8.74e-05	0.000231	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—KISS1R—stomach cancer	8.65e-05	0.000228	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GLI3—stomach cancer	8.65e-05	0.000228	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SMAD4—stomach cancer	8.63e-05	0.000228	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—KRAS—stomach cancer	8.4e-05	0.000222	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RBP1—stomach cancer	8.25e-05	0.000218	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—FYN—stomach cancer	8.19e-05	0.000216	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—PIK3CA—stomach cancer	8.16e-05	0.000215	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—RGS2—stomach cancer	8.11e-05	0.000214	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—GAST—stomach cancer	8.11e-05	0.000214	CbGpPWpGaD
Olopatadine—S100A12—Immune System—ERBB2—stomach cancer	7.9e-05	0.000209	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—PIK3CA—stomach cancer	7.72e-05	0.000204	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—FGFR2—stomach cancer	7.69e-05	0.000203	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—HRAS—stomach cancer	7.55e-05	0.000199	CbGpPWpGaD
Olopatadine—S100B—Immune System—ERBB2—stomach cancer	7.47e-05	0.000197	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CDKN1B—stomach cancer	7.32e-05	0.000193	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—IL6—stomach cancer	7.23e-05	0.000191	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL1B—stomach cancer	7.19e-05	0.00019	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—HRAS—stomach cancer	7.14e-05	0.000189	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IRS2—stomach cancer	7.04e-05	0.000186	CbGpPWpGaD
Olopatadine—S100A12—Immune System—JUN—stomach cancer	6.96e-05	0.000184	CbGpPWpGaD
Olopatadine—S100B—Immune System—CDKN1B—stomach cancer	6.92e-05	0.000183	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—GSTP1—stomach cancer	6.92e-05	0.000183	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—IL6—stomach cancer	6.83e-05	0.00018	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CAV1—stomach cancer	6.83e-05	0.00018	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	6.82e-05	0.00018	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—APOA1—stomach cancer	6.81e-05	0.00018	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL1B—stomach cancer	6.8e-05	0.000179	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—AGTR2—stomach cancer	6.77e-05	0.000179	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CDKN1A—stomach cancer	6.75e-05	0.000178	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—WWOX—stomach cancer	6.72e-05	0.000178	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—F2R—stomach cancer	6.69e-05	0.000177	CbGpPWpGaD
Olopatadine—S100A12—Immune System—MAPK8—stomach cancer	6.59e-05	0.000174	CbGpPWpGaD
Olopatadine—S100B—Immune System—JUN—stomach cancer	6.59e-05	0.000174	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—HTR1A—stomach cancer	6.51e-05	0.000172	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PRKCB—stomach cancer	6.5e-05	0.000172	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL6ST—stomach cancer	6.47e-05	0.000171	CbGpPWpGaD
Olopatadine—S100B—Immune System—CDKN1A—stomach cancer	6.38e-05	0.000169	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—GSTM1—stomach cancer	6.36e-05	0.000168	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—ANXA1—stomach cancer	6.29e-05	0.000166	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	6.27e-05	0.000166	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HRH4—stomach cancer	6.25e-05	0.000165	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—WIF1—stomach cancer	6.25e-05	0.000165	CbGpPWpGaD
Olopatadine—S100B—Immune System—MAPK8—stomach cancer	6.23e-05	0.000165	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—APC—stomach cancer	6.22e-05	0.000164	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—AGTR2—stomach cancer	6.15e-05	0.000162	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—ADRB1—stomach cancer	6.09e-05	0.000161	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—F2R—stomach cancer	6.08e-05	0.00016	CbGpPWpGaD
Olopatadine—S100A12—Immune System—STAT3—stomach cancer	6.02e-05	0.000159	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ACAD8—stomach cancer	5.95e-05	0.000157	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HTR1A—stomach cancer	5.92e-05	0.000156	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL6R—stomach cancer	5.78e-05	0.000153	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PRKAB1—stomach cancer	5.77e-05	0.000152	CbGpPWpGaD
Olopatadine—S100A12—Immune System—MAPK3—stomach cancer	5.76e-05	0.000152	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—stomach cancer	5.75e-05	0.000152	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—ANXA1—stomach cancer	5.71e-05	0.000151	CbGpPWpGaD
Olopatadine—S100B—Immune System—STAT3—stomach cancer	5.7e-05	0.00015	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RNF43—stomach cancer	5.57e-05	0.000147	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—KISS1—stomach cancer	5.57e-05	0.000147	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	5.54e-05	0.000146	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—ADRB1—stomach cancer	5.53e-05	0.000146	CbGpPWpGaD
Olopatadine—S100A12—Immune System—MAPK1—stomach cancer	5.48e-05	0.000145	CbGpPWpGaD
Olopatadine—S100A12—Immune System—EGFR—stomach cancer	5.48e-05	0.000145	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—stomach cancer	5.47e-05	0.000144	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—stomach cancer	5.47e-05	0.000144	CbGpPWpGaD
Olopatadine—S100B—Immune System—MAPK3—stomach cancer	5.44e-05	0.000144	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SERPINE1—stomach cancer	5.41e-05	0.000143	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—PIK3CA—stomach cancer	5.31e-05	0.00014	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GMPR2—stomach cancer	5.3e-05	0.00014	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—RHOA—stomach cancer	5.22e-05	0.000138	CbGpPWpGaD
Olopatadine—S100B—Immune System—MAPK1—stomach cancer	5.18e-05	0.000137	CbGpPWpGaD
Olopatadine—S100B—Immune System—EGFR—stomach cancer	5.18e-05	0.000137	CbGpPWpGaD
Olopatadine—S100A12—Immune System—KRAS—stomach cancer	5.17e-05	0.000137	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	5.17e-05	0.000136	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NOS3—stomach cancer	5.16e-05	0.000136	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FST—stomach cancer	4.97e-05	0.000131	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—ADRB2—stomach cancer	4.94e-05	0.00013	CbGpPWpGaD
Olopatadine—S100B—Immune System—KRAS—stomach cancer	4.89e-05	0.000129	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HBEGF—stomach cancer	4.86e-05	0.000128	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SUCLG1—stomach cancer	4.85e-05	0.000128	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—IDH3B—stomach cancer	4.85e-05	0.000128	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—ERBB2—stomach cancer	4.83e-05	0.000128	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GAST—stomach cancer	4.79e-05	0.000127	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RGS2—stomach cancer	4.79e-05	0.000127	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PIK3CA—stomach cancer	4.75e-05	0.000125	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	4.75e-05	0.000125	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CXCL8—stomach cancer	4.58e-05	0.000121	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FGG—stomach cancer	4.54e-05	0.00012	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NDUFV1—stomach cancer	4.51e-05	0.000119	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NDUFS1—stomach cancer	4.51e-05	0.000119	CbGpPWpGaD
Olopatadine—S100B—Immune System—PIK3CA—stomach cancer	4.49e-05	0.000119	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—ADRB2—stomach cancer	4.48e-05	0.000118	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CDKN1B—stomach cancer	4.47e-05	0.000118	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HRAS—stomach cancer	4.4e-05	0.000116	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PPP2R1A—stomach cancer	4.39e-05	0.000116	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	4.39e-05	0.000116	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PRKAA1—stomach cancer	4.37e-05	0.000115	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCND1—stomach cancer	4.27e-05	0.000113	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—JUN—stomach cancer	4.26e-05	0.000112	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RBP4—stomach cancer	4.22e-05	0.000111	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CXCL8—stomach cancer	4.22e-05	0.000111	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL6—stomach cancer	4.21e-05	0.000111	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	4.2e-05	0.000111	CbGpPWpGaD
Olopatadine—S100B—Immune System—HRAS—stomach cancer	4.16e-05	0.00011	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MMP9—stomach cancer	4.14e-05	0.000109	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CDKN1A—stomach cancer	4.13e-05	0.000109	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MAPK8—stomach cancer	4.03e-05	0.000106	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PGLS—stomach cancer	4.02e-05	0.000106	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—BLVRB—stomach cancer	4.02e-05	0.000106	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL6—stomach cancer	3.98e-05	0.000105	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPAP2A—stomach cancer	3.83e-05	0.000101	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—VEGFA—stomach cancer	3.72e-05	9.82e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—STAT3—stomach cancer	3.68e-05	9.73e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HSPB1—stomach cancer	3.63e-05	9.59e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AGTR2—stomach cancer	3.63e-05	9.59e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—F2R—stomach cancer	3.59e-05	9.48e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—BMP2—stomach cancer	3.59e-05	9.48e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AKR1C3—stomach cancer	3.53e-05	9.33e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MAPK3—stomach cancer	3.52e-05	9.29e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HTR1A—stomach cancer	3.49e-05	9.23e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MYC—stomach cancer	3.42e-05	9.04e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—FBP1—stomach cancer	3.41e-05	9.02e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CKB—stomach cancer	3.41e-05	9.02e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NDUFA2—stomach cancer	3.41e-05	9.02e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CA1—stomach cancer	3.41e-05	9.02e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PRKCB—stomach cancer	3.38e-05	8.94e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ANXA1—stomach cancer	3.38e-05	8.91e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MAPK1—stomach cancer	3.35e-05	8.84e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—EGFR—stomach cancer	3.35e-05	8.84e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ADRB1—stomach cancer	3.27e-05	8.63e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PLIN2—stomach cancer	3.21e-05	8.48e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—KRAS—stomach cancer	3.16e-05	8.35e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CA2—stomach cancer	3.12e-05	8.25e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RPS6—stomach cancer	3.12e-05	8.25e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PRKCB—stomach cancer	3.07e-05	8.11e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL6ST—stomach cancer	3.06e-05	8.08e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NT5E—stomach cancer	3.04e-05	8.04e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PGAM1—stomach cancer	3.04e-05	8.04e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PIK3CA—stomach cancer	2.91e-05	7.67e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PLCE1—stomach cancer	2.9e-05	7.67e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALDH7A1—stomach cancer	2.9e-05	7.67e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HBEGF—stomach cancer	2.87e-05	7.58e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TP53—stomach cancer	2.81e-05	7.42e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—UMPS—stomach cancer	2.78e-05	7.35e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL6R—stomach cancer	2.73e-05	7.21e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—RHOA—stomach cancer	2.72e-05	7.17e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HRAS—stomach cancer	2.69e-05	7.1e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ADRB2—stomach cancer	2.65e-05	6.99e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PPP2R1A—stomach cancer	2.6e-05	6.85e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PDHA1—stomach cancer	2.59e-05	6.83e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ECHS1—stomach cancer	2.59e-05	6.83e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL6—stomach cancer	2.57e-05	6.79e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—RHOA—stomach cancer	2.47e-05	6.51e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—FADS1—stomach cancer	2.43e-05	6.43e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—TYMP—stomach cancer	2.43e-05	6.43e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SMAD4—stomach cancer	2.41e-05	6.36e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CXCL8—stomach cancer	2.38e-05	6.3e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FYN—stomach cancer	2.29e-05	6.04e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SREBF2—stomach cancer	2.28e-05	6.02e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—RORA—stomach cancer	2.25e-05	5.95e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CXCL8—stomach cancer	2.17e-05	5.72e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FGFR2—stomach cancer	2.15e-05	5.67e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALDOB—stomach cancer	2.11e-05	5.57e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IRS2—stomach cancer	1.97e-05	5.19e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALOX5—stomach cancer	1.96e-05	5.18e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—DPYD—stomach cancer	1.93e-05	5.1e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CAV1—stomach cancer	1.91e-05	5.04e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APOA1—stomach cancer	1.9e-05	5.02e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PRKCB—stomach cancer	1.82e-05	4.79e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL6ST—stomach cancer	1.81e-05	4.77e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APC—stomach cancer	1.74e-05	4.59e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTT1—stomach cancer	1.71e-05	4.51e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.69e-05	4.45e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—MAPK3—stomach cancer	1.66e-05	4.39e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.64e-05	4.33e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL6R—stomach cancer	1.61e-05	4.26e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ENO1—stomach cancer	1.6e-05	4.22e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—MAPK1—stomach cancer	1.58e-05	4.18e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—EGFR—stomach cancer	1.58e-05	4.18e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PIK3CA—stomach cancer	1.51e-05	3.99e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SERPINE1—stomach cancer	1.51e-05	3.99e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—KRAS—stomach cancer	1.5e-05	3.95e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RHOA—stomach cancer	1.46e-05	3.85e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NOS3—stomach cancer	1.44e-05	3.81e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CD44—stomach cancer	1.42e-05	3.74e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PIK3CA—stomach cancer	1.37e-05	3.63e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ERBB2—stomach cancer	1.35e-05	3.56e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CXCL8—stomach cancer	1.28e-05	3.38e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HRAS—stomach cancer	1.27e-05	3.36e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CDKN1B—stomach cancer	1.25e-05	3.3e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL6—stomach cancer	1.22e-05	3.21e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.21e-05	3.18e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCND1—stomach cancer	1.19e-05	3.15e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—JUN—stomach cancer	1.19e-05	3.14e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTP1—stomach cancer	1.18e-05	3.12e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HMOX1—stomach cancer	1.17e-05	3.08e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MMP9—stomach cancer	1.16e-05	3.06e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CDKN1A—stomach cancer	1.15e-05	3.04e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MAPK8—stomach cancer	1.13e-05	2.97e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—TYMS—stomach cancer	1.1e-05	2.9e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTM1—stomach cancer	1.09e-05	2.87e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—VEGFA—stomach cancer	1.04e-05	2.74e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—STAT3—stomach cancer	1.03e-05	2.72e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ERCC2—stomach cancer	1.02e-05	2.7e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MAPK3—stomach cancer	9.83e-06	2.6e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—MTHFR—stomach cancer	9.61e-06	2.54e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MYC—stomach cancer	9.56e-06	2.52e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MAPK1—stomach cancer	9.35e-06	2.47e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—EGFR—stomach cancer	9.35e-06	2.47e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CAV1—stomach cancer	8.86e-06	2.34e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOA1—stomach cancer	8.84e-06	2.33e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—KRAS—stomach cancer	8.83e-06	2.33e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PIK3CA—stomach cancer	8.11e-06	2.14e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TP53—stomach cancer	7.85e-06	2.07e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPARG—stomach cancer	7.79e-06	2.06e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HRAS—stomach cancer	7.51e-06	1.98e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL6—stomach cancer	7.19e-06	1.9e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALB—stomach cancer	7e-06	1.85e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NOS3—stomach cancer	6.7e-06	1.77e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PTGS2—stomach cancer	6.13e-06	1.62e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PIK3CA—stomach cancer	3.77e-06	9.95e-06	CbGpPWpGaD
